The effects of tiazofurin on basal and amphetamine-induced motor activity in rats

Pharmacology Biochemistry and Behavior

Volumn 77, Issue 3, 2004, Pages 575-582

  Janać, Branka ^a   Pešić, Vesna ^a   Veskov, Rosica ^a   Ristić, Slavica ^b   Tasić, Jelena ^b   Piperski, Vesna ^b   Ruždijić, Sabera ^a   Jokanović, Milan ^b   Stukalov, Petar ^c   Rakić, Ljubiša ^d  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b ICN Galenika Institute   (Serbia)

^c CLINICAL CENTER OF SERBIA   (Serbia)

^d SERBIAN ACADEMY OF SCIENCES AND ARTS   (Serbia)

Author keywords

Amphetamine; HPLC; Motor activity; Open field; Rat brain; Tiazofurin

Indexed keywords

AMPHETAMINE; PURINE NUCLEOSIDE DERIVATIVE; TIAZOFURIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG BRAIN LEVEL; DRUG EFFECT; DRUG MEGADOSE; DRUG TISSUE LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LOCOMOTION; LOW DRUG DOSE; MALE; MOTOR ACTIVITY; NONHUMAN; PREMEDICATION; PRIORITY JOURNAL; RAT; STEREOTYPY;

ANIMALIA; RATTUS NORVEGICUS;

EID: 10744222514     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2003.12.025     Document Type: Article

References (41)

1. Alexander S.P., Reddington M. The cellular localization of adenosine receptors in rat neostriatum. Neuroscience. 28:1989;645-651.
2. Ballarin M., Reiriz J., Ambrosio S., Mahy N. Effect of locally infused 2-chloroadenosine, an A1 receptor agonist, on spontaneous and evoked dopamine release in rat neostriatum. Neurosci. Lett. 185:1995;29-32.
3. Barraco R.A., Martens K.A., Parizon M., Normile H.J. Adenosine A2a receptors in the nucleus accumbens mediate locomotor depression. Brain Res. Bull. 31:1993;397-404.
4. Barraco R.A., Martens K.A., Parizon M., Normile H.J. Role of adenosine A2a receptors in the nucleus accumbens. Prog. Neuro-psychopharmacol. Biol. Psychiatry. 18:1994;545-553.
5. Creese I., Iversen S.D. The role of forebrain dopamine systems in amphetamine induced stereotyped behavior in the rat. Psychopharmacologia (Berl.). 39:1974;345-357.
6. Drabek K., Pesic M., Piperski V., Ruzdijic S., Medic-Mijacevic L.J., Pietrzkowski Z.et al. 8-Cl-cAMP and tiazofurin affect vascular endothelial growth factor production and glial fibrillary acidic protein expression in human glioblastoma cells. Anti-Cancer Drugs. 11:2000;765-770.
7. Dunwiddie T.V., Fredholm B.B. Adenosine A1 receptors inhibit adenylate cyclase activity and neurotransmitter release and hyperpolarize pyramidal neurons in rat hippocampus. J. Pharmacol. Exp. Ther. 249:1989;31-37.
8. Ferre S., O'Connor W.T., Fuxe K., Ungerstedt U. The striopallidal neuron: a main locus for adenosine-dopamine interactions in the brain. J. Neurosci. 13:1993;5402-5406.
9. Ferre S., Popoli P., Gimenez-Llort L., Finnman U.B., Martinez E., Scotti de Carolis A.et al. Postsynaptic antagonistic interaction between adenosine A1 and dopamine D1 receptors. NeuroReport. 6:1994;73-76.
10. Ferre S., Fredholm B.B., Morelli M., Popoli P., Fuxe K. Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia. Trends Neurosci. 20:1997;482-487.
11. Fink J.S., Smith G.P. Relationships between selective denervation of dopamine terminal fields in the anterior forebrain and behavioral responses to amphetamine and apomorphine. Brain Res. 201:1980;107-127.
12. Franchetti P., Cappellacci L., Grifantini M., Senatore G., Martini C., Lucacchini A. Tiazofurin analogues as selective agonists of A1 adenosine receptors. Res. Commun. Mol. Pathol. Pharmacol. 87:1995;103-105.
13. Fredholm B.B., Dunwiddie T.V. How does adenosine inhibit transmitter release? Trends Pharmacol. Sci. 9:1988;130-134.
14. Fuxe K., Ferre S., Zoli M., Agnati L.F. Integrated events in central dopamine transmission as analyzed at multiple levels. Evidence for intramembrane adenosine A2a/dopamine D2 and adenosine A1/dopamine D1 receptor interactions in the basal ganglia. Brain Res. Rev. 26:1998;258-273.
15. Gines S., Hillion J., Torvinen M., Le Crom S., Casado V., Canela E.I.et al. Dopamine D1 and adenosine A1 receptors form functionally interacting heteromeric complexes. Proc. Natl. Acad. Sci. U. S. A. 97:2000;8606-8611.
16. Grifantini M. Tiazofurine ICN pharmaceuticals. Curr. Opin. Investig. Drugs. 1:2000;257-262.
17. Heffner T.G., Wiley J.N., Williams A.E., Bruns R.F., Coughenour L.L., Downs D.A. Comparison of the behavioral effects of adenosine agonists and dopamine antagonists in mice. Psychopharmacology. 98:1989;31-37.
18. Marston H.M., Finlayson K., Maemoto T., Olverman H.J., Akahane A., Sharkey J.et al. Pharmacological characterization of a simple behavioral response mediated selectively by central adenosine A1 receptors, using in vivo and in vitro techniques. J. Pharmacol. Exp. Ther. 285:1998;1023-1030.
19. Nikodijevic O., Sarges R., Daly J.W., Jacobson K.A. Behavioral effects of A1- and A2-selective adenosine agonists and antagonists: evidence for synergism and antagonism. J. Pharmacol. Exp. Ther. 259:1991;286-294.
20. Ochiishi T., Chen L., Yukawa A., Saitoh Y., Sekino Y., Arai T.et al. Cellular localization of adenosine A1 receptors in rat forebrain: immunohistochemical analysis using adenosine A1 receptor-specific monoclonal antibody. J. Comp. Neurol. 411:1999;301-316.
21. Okada M., Mizuno K., Kaneko S. Adenosine A1 and A2 receptors modulate extracellular dopamine levels in rat striatum. Neurosci. Lett. 212:1996;53-56.
22. Paxinos G., Watson C. The rat brain in stereotaxic coordinates. 2nd ed. 1986;Academic Press, San Diego.
23. Pesic M., Drabek K., Esler C., Ruzdijic S., Pejanovic V., Pietrzkowski Z. Inhibition of cell growth and proliferation in human glioma cells and normal human astrocytes induced by 8-Cl-cAMP and tiazofurin. Nucleosides Nucleotides Nucleic Acids. 19:2000;963-975.
24. Piperski V., Vracar M., Jokanovic M., Stukalov P., Rakic L. Detection of apoptosis and phagocytosis in vitro in C6 rat glioma cells treated with tiazofurin. Apoptosis. 3:1998;345-352.
25. Popoli P., Gimenez-Llort L., Pezzola A., Reggio R., Martinez E., Fuxe K.et al. Adenosine A1 receptor blockade selectively potentiates the motor effects induced by dopamine D1 receptor stimulation in rodents. Neurosci. Lett. 218:1996;209-213.
26. Prince D.A., Stevens C.F. Adenosine decreases neurotransmitter release at central synapses. Proc. Natl. Acad. Sci. U. S. A. 89:1992;8586-8590.
27. Redzic Z.B., Markovic I.D., Jovanovic S.S., Gasic J.M., Mitrovic D.M., Zlokovic B.V.et al. Kinetics and sodium independence of [3H]-tiazofurin blood to brain transport in the guinea pig. Methods Find. Exp. Clin. Pharmacol. 18:1996;413-418.
28. Rivkees S.A., Price S.L., Zhou F.C. Immunohistochemical detection of A1 adenosine receptors in rat brain with emphasis on localization in the hippocampal formation, cerebral cortex, cerebellum, and basal ganglia. Brain Res. 677:1995;193-203.
29. Robins R.K. Nucleoside and nucleotide inhibitors of inosine monophosphate (IMP) dehydrogenase as potential antitumor inhibitors. Nucleosides Nucleotides. 1:1982;35-44.
30. 2+ currents and synaptic transmission in cultured rat hippocampal pyramidal neurons. J. Physiol. 435:1991;373-393.
31. Schwienbacher I., Fendt M., Hauber W., Koch M. Dopamine D1 receptors and adenosine A1 receptors in the rat nucleus accumbens regulate motor activity but not prepulse inhibition. Eur. J. Pharmacol. 444:2002;161-169.
32. Seiden L.S., Sabol K.E., Ricaurte G.A. Amphetamine: effects on catecholamine systems and behaviour. Annu. Rev. Pharmacol. Toxicol. 33:1993;639-677.
33. Sharp T., Zetterstrom T., Ljungberg T., Ungerstedt U. A direct comparison of amphetamine-induced behaviours and regional brain dopamine release in the rat using intracerebral dialysis. Brain Res. 401:1987;322-330.
34. Staton D.M., Solomon P.R. Microinjections of D-amphetamine into the nucleus accumbens and caudate-putamen differentially affect stereotypy and locomotion in the rat. Physiol. Psychol. 12:1984;159-162.
35. Stosic-Grujicic S., Savic-Radojevic A., Maksimovic-Ivanic D., Markovic M., Bumbasirevic V., Ramic Z.et al. Down-regulation of experimental allergic encephalomyelitis in DA rats by tiazofurin. J. Neuroimmunol. 130:2002;66-77.
36. Tasic J., Ristic S., Piperski V., Dacevic M., Pejanovic V., Jokanovic M.et al. Simultaneous LC determination of tiazofurin, its acetyl and benzoyl esters and their active metabolit thiazole-4-carboxamide adenine dinucleotide in biological samples. J. Pharm. Biomed. Anal. 30:2002;993-999.
37. Trussell L.O., Jackson M.B. Adenosine-activated potassium conductance in cultured striatal neurons. Proc. Natl. Acad. Sci. U. S. A. 82:1985;4857-4861.
38. Turgeon S.M., Pollack A.E., Schusheim L., Fink J.S. Effects of selective adenosine A1 and A2a agonists on amphetamine-induced locomotion and c-fos in striatum and nucleus accumbens. Brain Res. 707:1996;75-80.
39. Weber G., Prajda N., Abonyi M., Look K.Y., Tricot G. Tiazofurin: molecular and clinical action. Anticancer Res. 16:1996;3313-3322.
40. Wu L., Saggau P. Adenosine inhibits evoked synaptic transmission primarily by reducing presynaptic calcium influx in area CA1 of hippocampus. Neuron. 12:1994;1139-1148.
41. Zar J.H. Biostatistical analysis. 1984;Prentice-Hall, New Jersey.